Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro
Olaposi Idowu Omotuyi, Olusina M. Olatunji, Oyekanmi Nash, Babatunji Emmanuel Oyinloye, Opeyemi Soremekun, Ayodeji A. Ijagbuji, Segun Fatumo
Topics & Concepts
BenzimidazoleDocking (animal)ChemistryBinding siteCoronavirusComputational biologyBiochemistryPharmacologyBiologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)MedicineDiseaseOrganic chemistryPathologyNursingSARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies